A woman with hopes to conceive was diagnosed with severe vasospastic angina (VSA); however, she was able to carry a healthy baby to full term without angina attacks after starting treatment of a calcium channel blocker, according to a case published in a special Cardio-Obstetrics issue of JACC: Case Reports.
Data Insights – Pharmaceutical Technology
By Company Name No Filter Selected Bristol-Myers Squibb (370) Merck (239) AstraZeneca (190) Novartis (162) AbbVie (145) BeiGene (136) Pfizer (123) F. Hoffmann-La Roche (122)